These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 15526241

  • 21. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR, Krum H.
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [Abstract] [Full Text] [Related]

  • 22. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G, Sabbadini G, Zecchin M, Di Lenarda A.
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [Abstract] [Full Text] [Related]

  • 23. Heart failure management. Interview with Karl Swedberg.
    Swedberg K.
    Timely Top Med Cardiovasc Dis; 2007 Jan 09; 11():E1. PubMed ID: 17369884
    [No Abstract] [Full Text] [Related]

  • 24. Heart failure: recent advances in prevention and treatment.
    Fonarow GC.
    Rev Cardiovasc Med; 2000 Jan 09; 1(1):25-33, 54. PubMed ID: 12457149
    [Abstract] [Full Text] [Related]

  • 25. [Management of advanced chronic heart failure].
    Oliva F, Macera F, Verde A, Frigerio M.
    G Ital Cardiol (Rome); 2008 Oct 09; 9(10 Suppl 1):112S-117S. PubMed ID: 19195318
    [Abstract] [Full Text] [Related]

  • 26. Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
    Jessup M, Banner N, Brozena S, Campana C, Costard-Jäckle A, Dengler T, Hunt S, Metra M, Rahmel A, Renlund D, Ross H, Warner Stevenson L.
    J Heart Lung Transplant; 2006 Sep 09; 25(9):1003-23. PubMed ID: 16962463
    [No Abstract] [Full Text] [Related]

  • 27. [Medical management of chronic systolic heart failure].
    Galinier M.
    Rev Prat; 2010 Sep 20; 60(7):941-6. PubMed ID: 21033491
    [Abstract] [Full Text] [Related]

  • 28. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.
    Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Buch P, Sørensen R, Folke F, Gadsbøll N, Rasmussen S, Køber L, Madsen M, Torp-Pedersen C.
    Circulation; 2007 Aug 14; 116(7):737-44. PubMed ID: 17646585
    [Abstract] [Full Text] [Related]

  • 29. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G, Di Lenarda A, Metra M, Nodari S, Moretti M, Brentana L, Dei Cas L, Sinagra G.
    Ital Heart J; 2004 Dec 14; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [Abstract] [Full Text] [Related]

  • 30. An approach to heart failure and diabetes mellitus.
    Fonarow GC.
    Am J Cardiol; 2005 Aug 22; 96(4A):47E-52E. PubMed ID: 16098844
    [Abstract] [Full Text] [Related]

  • 31. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H, Gilbert RE.
    J Hypertens; 2007 Jan 22; 25(1):25-35. PubMed ID: 17143168
    [Abstract] [Full Text] [Related]

  • 32. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.
    de Groote P, Isnard R, Assyag P, Clerson P, Ducardonnet A, Galinier M, Jondeau G, Leurs I, Thébaut JF, Komajda M.
    Eur J Heart Fail; 2007 Dec 22; 9(12):1205-11. PubMed ID: 18023249
    [Abstract] [Full Text] [Related]

  • 33. [Inhibition of renin-angiotensin-aldosterone system: what evidence?].
    Mota T.
    Rev Port Cardiol; 2001 Mar 22; 20 Suppl 3():13-5. PubMed ID: 11409069
    [Abstract] [Full Text] [Related]

  • 34. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan 22; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 35. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H, Moukarbel GV, Dawson B, Hajjar RJ, Francis GS.
    Am J Med; 2007 Dec 22; 120(12):1090.e1-8. PubMed ID: 18060931
    [Abstract] [Full Text] [Related]

  • 36. Guidelines for choosing drugs in chronic heart failure.
    Tabrizchi R.
    Vasc Health Risk Manag; 2005 Dec 22; 1(3):171-2. PubMed ID: 17319102
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacologic advances in long-term heart failure management.
    Pfeffer MA.
    Am Heart Hosp J; 2004 Dec 22; 2(4 Suppl 1):15-20. PubMed ID: 15539971
    [Abstract] [Full Text] [Related]

  • 38. Use of valsartan in post-myocardial infarction and heart failure patients.
    Liu PP, Maggioni A, Velazquez EJ.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun 22; 7 Suppl 1():S19-22. PubMed ID: 16986231
    [Abstract] [Full Text] [Related]

  • 39. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F, Müller-Tasch T, Remppis A, Szecsenyi J, Schellberg D.
    J Eval Clin Pract; 2008 Oct 22; 14(5):823-9. PubMed ID: 19018915
    [Abstract] [Full Text] [Related]

  • 40. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR.
    An R Acad Nac Med (Madr); 2006 Oct 22; 123(3):617-30. PubMed ID: 17451101
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.